Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation

Brain

Volumn 123, Issue 12, 2000, Pages 2467-2474

  Singleton, Andrew B ^a,f   Hall, Ros ^a   Ballard, Clive G ^a   Perry, Robert H ^a   Xuereb, John H ^b   Rubinsztein, David C ^b   Tysoe, Carolyn ^b,g   Matthews, Paul ^c   Cordell, Barbara ^d   Kumar Singh, Samir ^e   De Jonghe, Chris ^e   Cruts, Marc ^e   Van Broeckhoven, Christine ^e   Morris, Christopher M ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d Scios Nova Inc   (United States)

^e DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^f MAYO CLINIC   (United States)

^g CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid; Mutation; Pathology; Presenilin

Indexed keywords

AMINO ACID; MESSENGER RNA; PRESENILIN 1; THREONINE;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; GENE INSERTION; GENE MUTATION; HUMAN; INTRON; MISSENSE MUTATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

EID: 0033634890     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.12.2467     Document Type: Article

References (34)

1. Presenilin mutations in Alzheimer's disease
2. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease
3. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion
4. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age
5. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor
6. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
7. Chromosome 14-encoded Alzheimer's disease: Genetic and clinicopathological description
8. Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain
9. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain
10. Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease
11. The clinical phenotype of two missense mutations in the presenilin 1 gene in Japanese patients
12. Increased Aβ42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene
13. Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid beta 42(43) deposit in diffuse plaques
14. 42 in neocortical and cerebrovascular amyloid β deposits in Swedish familial Alzheimer's disease and Down's syndrome
15. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred
16. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology
17. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation
18. Amyloid β protein (Aβ) deposition in chromosome 14-linked Alzheimer's disease: Predominance of Aβ42-(43)
19. Heterogeneity in dementia of the Alzheimer type. Evidence of subgroups
20. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
21. Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias
22. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I)
23. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene
24. Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls
25. Alzheimer disease PS-1 exon 9 deletion defined
26. Identification of glutamine and lysine residues in Alzheimer amyloid beta A4 peptide responsible for transglutaminase-catalysed homopolymerization and cross-linking to alpha 2M receptor
27. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
28. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases
29. Neuritic plaque amyloid in Alzheimer's disease is highly racemized
30. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
31. Apolipoprotein E and Alzheimer's disease
32. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer's disease
33. Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer's disease
34. A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy